Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Sharma

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 8, 2024
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosisMarc Pallardy, Rami Bechara, Jessica Whritenour, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
Animal models of idiosyncratic drug reactionsWinnie Ng, Alexandra R M Lobach, Xu Zhu, et al.
Frontiers in Pharmacology|June 18, 2024
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapyRajbharan Yadav, Suzanne Schubbert, Patrick G Holder, et al.
NPJ Vaccines|October 7, 2024
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccinesTeresa Hauguel, Amy Sharma, Emily Mastrocola, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 8, 2024
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosisMarc Pallardy, Rami Bechara, Jessica Whritenour, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 18, 2022
Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus MonkeysTod Harper, Amy Sharma, Sarav Kaliyaperumal, et al.
Advances in Pharmacology (San Diego, Calif.)|July 11, 2012
Animal models of idiosyncratic drug reactionsWinnie Ng, Alexandra R M Lobach, Xu Zhu, et al.
Frontiers in Pharmacology|June 18, 2024
Translational PK/PD and the first-in-human dose selection of a PD1/IL15: an engineered recombinant targeted cytokine for cancer immunotherapyRajbharan Yadav, Suzanne Schubbert, Patrick G Holder, et al.
NPJ Vaccines|October 7, 2024
Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccinesTeresa Hauguel, Amy Sharma, Emily Mastrocola, et al.
Pageof 2